the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories

[Report]

Can a New Antidepressant Establish Itself in a Highly Competitive Market?

Published: 2008/03

Contact 24 hrs/day
Table of Contents

Abstract

Introduction

With the antidepressant market approaching its saturation point, emerging agents face increasing diffi culty capturing market share from the multitude of already available branded and generic drugs. Companies hoping to launch new products into this market must explore and capitalize on fresh ways of marketing their agents, such as emphasizing their drugs' collateral benefi ts for comorbid conditions, and carefully allocate and target their advertising budgets.

Get the Answers You Need to Shape Your Strategy

  • SSRIs are the fi rst-line therapy choice for most depressive disorders, although psychiatrists are increasingly prescribing SNRIs. Do patients consult PCPs or psychiatrists for help with their depressive disorders? What agents do physicians prefer? What role do reimbursement considerations play in prescribing habits?
  • With dozens of antidepressants on the market, including a number of generic agents, it is becoming increasingly diffi cult for manufacturers of these agents to distinguish their products. What strategies have antidepressant manufacturers used to position their products? How well have these strategies succeeded? What strategies can be used to distinguish emerging agents?
  • Branded antidepressants consistently have some of the highest promotional budgets among all pharmaceuticals. What is the correlation between promotional spend and drug sales? How does directto-consumer (DTC) advertising affect the uptake of a drug?

Scope

  • Overview of antidepressants: tricyclics, monoamine oxidase inhibitors, SSRIs, SNRIs, dopaminergic/noradrenergic agents.
  • Prescribing habits of physicians: treatment algorithms for major depression and bipolar disorder, physicians' choices of agents.
  • Market for antidepressants: 2007 sales, generic erosion patterns for antidepressants, role of managed care in the market.
  • Marketing strategies for antidepressants: Zoloft, Lexapro, Cymbalta, Pristiq, agomelatine.
  • Market outlook: the value of promotional spend, the value of DTC advertising, marketing strategies for emerging agents.
Table of Contents

[Report]
Can a New Antidepressant Establish Itself in a Highly Competitive Market?
Published: 2008/03
Published by : Decision Resources, Inc. Decision Resources, Inc.

Price:
US $ 2,225.00 PDF by E-mail (Single User License)
>
Product Code : DR63871
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.